Evaluation of the Traq Device for Measuring Eye Function in People With and Without Recent Mild to Moderate Traumatic Brain Injury

What this Trial Is About

Researchers are investigating the Traq device, a binocular ophthalmic neurodiagnostic tool, to measure eye function in both healthy individuals and those who have experienced mild to moderate traumatic brain injury mTBI within the past six months. This early prospective study aims to characterize differences in binocular ocular functions such as bilateral foveal fixation, foveal binocularity, and saccadic eye movement latency between these two groups. Participants will be divided into two groups those with a recent history of head trauma post-TBI arm and those without any history of head trauma normal arm. The study involves non-invasive eye function measurements using the Traq device, with no treatment or intervention administered. Measurements will be taken through four individual scans scheduled on Day 0, Day 30, Day 60, and Day 90 to track eye function over time. During the study, participants will attend scheduled visits for eye testing and assessments using the device. Researchers will collect data on device metrics including foveal fixation and other ocular outputs. The study requires participants to complete all visits and assessments, ensuring close monitoring of binocular visual function changes. The total duration of participation spans approximately three months, with follow-up scans at regular intervals.

An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury